Home Vedere Bio

Vedere Bio

Out of service
Series A
Developer of Ocular Gene Therapy Products
Basic
Enterprise Profile

Basic Information

Vedere Bio, composed of a diverse team of pioneering scientists, is discovering and developing next-generation ocular gene therapy products to restore functional vision in patients blinded by inherited retinal degenerations (IRDs), as well as other genetic and non-genetic causes of vision loss. With their ocular gene therapy toolkit, they focus on high-quality vision restoration and preservation to bring life-changing technologies to patients worldwide.
Vedere Bio II, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2019
info@vederebio.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Biological Product Manufacturing
Technology
Gene Technology
Concept
Ophthalmology Disease Treatment Ocular Diseases
Application Scenarios
Innovative Drugs Prescription Drug Cell and Gene Therapy